All articles by Manish Kumar
Manish Kumar
Creative Diagnostics unveils Norovirus VP1 VLP Research Panel
This Norovirus panel helps researchers develop diagnostics, vaccines, and study a broader spectrum of norovirus diversity for advanced research
Marine Biological Laboratory develops hybrid microscope for 3D imaging of cell molecules
The hybrid microscope combines polarised-fluorescence technology and a diSPIM microscope to measure molecular orientation and image samples along the depth axis.
New study shows improved accuracy with Nevisense for US and German dermatologists
The article compares two corresponding studies, one conducted in the US and one in Germany, with the aim to evaluate how Nevisense (EIS) impacted dermatologist’s biopsy decisions
Coreline Soft leads AI medical imaging innovation at STR 2025
Introducing the AVIEW lineup specialized in simultaneous diagnosis and analysis of thoracic diseases
BIOTRONIK launches BIOMAG-LL trial for Freesolve RMS in coronary treatment
The BIOMAG-LL trial will evaluate the safety and performance of the Freesolve RMS in treating long de novo coronary artery lesions in 100 patients across Europe
Neurogen partners with Quanterix to advance early dementia detection
Both companies will market ultrasensitive dementia and MCI detection technology in the US, Europe, and pan-Asia for direct-to-consumer use
VitalConnect secures $100m in financing
Latest Funding Accelerates the Company’s Commercial Expansion
Hologic receives FDA approval for Aptima SARS-CoV-2 assay
The assay is designed to detect SARS-CoV-2 RNA from nasopharyngeal or nasal swabs in individuals showing symptoms of respiratory tract infections
Establishment Labs launches Preservé breast care technology in Brazil
Preservé preserves breast tissue during aesthetic surgery, offering more stable, natural outcomes while maintaining the breast’s structural anatomy and function
Clinical ink announces trial license for the SPUR AI-enabled Digital Engagement and Retention Solution
Industry-leading behavioral science tool SPUR is validated to predict adherence and will be offered through the Clinical ink technology platform